This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08981/identifier/chebi/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08981/identifier/wikipedia/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB08981/identifier/kegg-drug/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08981/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/atc/
n13http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB08981
rdf:type
n3:Drug
n3:description
Fenbufen is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation.
n3:group
approved
owl:sameAs
n12:DB08981
dcterms:title
Fenbufen
adms:identifier
n6:DB08981 n7:D01344 n8:31599 n10:Fenbufen
n3:synonym
3-(4-Phenylbenzoyl)propionic acid Fenbufen gamma-oxo(1,1'-Biphenyl)-4-butanoic acid 4-Biphenyl-4-yl-4-oxobutanoic acid 4-(4-Biphenylyl)-4-oxobutyric acid 3-(4-Biphenylylcarbonyl)propionic acid
n3:synthesisReference
U.S. Patent 3,784,701.
n3:IUPAC-Name
n4:271B61BE-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B61C4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B61C3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B61C0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B61C1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B61C2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B61BC-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B61BA-363D-11E5-9242-09173F13E4C5 n4:271B61BD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B61BB-363D-11E5-9242-09173F13E4C5
n13:hasATCCode
n14:M01AE05
n3:H-Bond-Acceptor-Count
n4:271B61CA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B61CB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B61C5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B61C6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B61C8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B61C7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B61C9-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
36330-85-5
n3:Bioavailability
n4:271B61D0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B61D2-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B61D3-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B61D4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B61CF-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B61CE-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B61D1-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B61BF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B61CC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B61CD-363D-11E5-9242-09173F13E4C5